Active Ingredient History

  • Now
Trimetazidine is a drug for angina pectoris sold under many brand names. Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France). It is an anti-ischemic (antianginal) metabolic agent of the fatty acid oxidation inhibitor class, meaning that it improves myocardial glucose utilization through inhibition of fatty acid metabolism.   Wikipedia

  • SMILES: COc1ccc(CN2CCNCC2)c(OC)c1OC
  • Mol. Mass: 266.34
  • ALogP: 1.12
  • ChEMBL Molecule:
More Chemistry
1-[2,3,4-trimethoxybenzyl] piperazine dihydrochloride | trimetazidine | trimetazidine dihydrochloride | trimetazidine hcl | trimetazidine hydrochloride | vastarel | vastarel mr


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue